Task: Answer Verification
Input (English): Question: Are s100A8 , S100A9 , and the S100A8/A9 complex in circulating blood associated with prostate cancer risk-A re-evaluation study?
Answer: Our re-evaluation study showed that S100A8, S100A9, and the complex S100A8/A9 were less indicative than %fPSA and that they are not suitable to replace PSA.
Output (English): no